<DOC>
	<DOCNO>NCT00263211</DOCNO>
	<brief_summary>The purpose study determine effect Plavix aspirin woman metastatic breast cancer .</brief_summary>
	<brief_title>A Study Effects Inhibiting Platelet Function Circulating Cancer Cells Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Women metastatic breast cancer complete plan course chemotherapy plan treatment break On stable hormone therapy least 2 month also eligible study Estimated survival least 3 month No platelet inhibitor therapy within 1 month study entry Platelets ≥ 100,000 Coagulation screening test within normal range ( INR 0.81 1.20 ) Normal kidney liver function define : Aspartate aminotransferase ( AST ) /serum glutamic oxaloacetic transaminase ( SGOT ) ) /alanine aminotransferase ( ALT ) ≤ 2 x Institutional Normal Creatinine ≤ 2 x Institutional Normal Able provide sign , informed consent . Patients go surgery Patients serious bleed disorder make inappropriate candidate NSAID therapy Patients history significant bleeding relate peptic ulcer disease Patients standing dos NSAIDS platelet function inhibitor Patients stand dos anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Platelet</keyword>
</DOC>